44 per share, with $92. large-cap stocks. XBI. 38%. "The top five holdings in XBI, as of Dec. Looking at the chart above, XBI's low point in its 52 week range is $62. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 20. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. As you can see from our holdings in the first chart, we have a sizable exposure to both the ProShares UltraPro QQQ ETF ( NASDAQ: TQQQ) and SPDR S&P Biotech ETF ( NYSEARCA: XBI ). ARKK Holdings / CRSP / ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily. 03 per $1,000 of principal). SPDR S&P Biotech ETF Stock Up 1. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. 95. Dividend Yield. The fee is slightly higher for SBIO - . Rated on Jun 30, 2023 Published on Jun 30. XBI has a beta of 1. 01 %IBB: iShares Biotechnology ETF: 0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 1. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. 8% of its total assets under management. 7% of assets. 01% upside for this ETF looking through to the average analyst targets of the underlying holdings. Asset type. Assets Under Management. While this ETF allocates. Currency in USD. S. 60 as the 52 week high point — that compares with a last trade of $69. 96%, and is down about -5. View and export this data back to 2006. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. 47%. 94 per share, with $107. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 79 as the 52 week high point — that compares with a last trade of $133. LABU has a lower 5-year return than XBI (-46. XBI focuses on health care investments and follows the S&P Biotech Index. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI's top 10 holdings account for about 11. 37% in the last one. XBI is an almost pure play on the biotechnology sector. XBI has lost 27. Looking at the chart above, XBI's low point in its 52 week range is $62. According to data from U. 31, 2021, are" XBI is an equal weight fund that rebalances each quarter. 12% over the last 12 months (as of 07/18/2023). 60%. 7. 1 Day NAV Change as of Nov 09, 2023. S. 67. In that past 52-week period, it has traded between $62. Analysis of these related ETFs and how they are trading may provide insight to this commodity. 250-391-1110. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 47 million over the past three months. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). Top 10 Holdings 16. We have highlighted five ETFs from different. Again, top 10 holdings. Oct 10, 2022 01:14PM EDT. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 1% vs 0. Currency in USD Follow 2W 10W 9M 72. VHT vs XBI. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. SBIO holds 79 companies vs. Warren Buffett is known for holding onto his S&P 500 stocks forever. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 42 billion worth of net assets. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI | A complete SPDR S&P Biotech ETF exchange traded fund overview by MarketWatch. There are 10 biotech ETFs that trade in the United States,. In addition to holding 155 positions, its top 10 holdings make up just 14. 06 as the 52 week high point — that compares with a last trade of $109. Advertisement. XBI Holdings 5 Beaten-Down ETFs to Buy Now. Top 10 Holdings XBI. SPDR S&P Biotech ETF Stock Up 1. 47 and a beta of 0. Top Holdings . $5. Cryptocurrency. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at , one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. 78% so far this year and in the past one year (as of 11/20/2023), respectively. com Ltd. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. In depth view into XBI Price including historical data from 2006, charts and stats. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 64 per share, with $174. Trade XBI with: Price/Earnings ttm 17. Net Expense Ratio. 54%. 86% so far this year and is down about -32. 89%. Rated on Jun 30, 2023 Published on Jun 30. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 07. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. It has a total of 153 holdings. Fund size is a good indication of how many other investors trust this fund. 7042%). Boron One Announces First Closing of Financing. com. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. Skip to main content. The ETF has lost about -12. 91 Billion . 00 (0. Themes & Subsectors ETFs. 15 per share, with $174. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Wix. 67. 04 per unit, that means that analysts see 73. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. LABD. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Holdings: ETFs offer investors an interest in a portfolio of securities and other underlying assets and are therefore quite. Meanwhile, XBI equal weights its holdings. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. For an ETF, this widget displays the top 10 constituents that make up the fund. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment. Visitors trend 2W 10W 9M. 41% so far, and is down about. Below is the comparison between XBI and XLV. Lucy Brewster | Nov 10, 2023. IBB vs. 08%. A few losers won't cause XBI to crash. View complete YINN exchange traded fund holdings for better informed ETF trading. 12 and $91. Dividend Yield. 01 per share, with $174. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. 99%. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. 00%) Most Recent Dividend 0. Its fund flows were negative $259. 97. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. 58%: Halozyme Therapeutics Inc:XLY News. The XBI has been a leader beating other ETFs YTD, up about 35% until today. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). View complete XLP exchange traded fund holdings for better informed ETF trading. 35%. Some of the top XBI holdings continue to defy the bear market. N/A. Quote. 81 and $134. 12% in the. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. , respectively. LABU has a higher expense ratio than XBI (1. underlying holdings of the fund. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. 2. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The equal weight fund, designed to deliver. The company has an 88. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. November 03, 2023 — 10:50 am EDT. Latest Holdings, Performance, AUM (from 13F, 13D) XBI - SPDR (R) S&P (R) Biotech ETF has disclosed 142 total holdings in their latest SEC filings. 66%, and is down about -18. Currency in USD Follow 2W 10W 9M 72. Visitors trend 2W 10W 9M. 3. 81 and $97. As of Oct 31 2023. View Top Holdings and Key Holding Information for iShares Biotechnology ETF (IBB). . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 64 per share, with $174. 94 per share, with $174. XBI is an equal-weight passively-managed biotech ETF while ARKG is an actively-managed genomics ETF. Research performance, expense ratio, holdings, and volatility to see if it's the. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. , including minimum market capitalization and. 46% YTD Daily Total ReturnETF Summary. , and Amgen Inc. com. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. Further, the fund owns $6. Lens & Shutter Holdings Ltd. AU. 79 as the 52 week high point — that compares with a last trade of $133. LABU. 50 down to $98. The XBI is a modified equally weighted index and includes many well known mid-cap stocks with momentum that are likely to move up in a sector rally. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. 06 as the 52 week high point — that compares with a last trade of $102. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. 2015. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 60 as the 52 week high point — that compares with a last trade of $70. 64 billion, a PE ratio of 11. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. 11. 0. 72%: Data delayed at least 15 minutes, as of Nov 16 2023 21:00 GMT. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol. 5. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. With XBI trading at a recent price near $122. Comparing the most. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 73. 66738-1. XBI has traded between $62. 28% IONS Ionis Pharmaceuticals Inc Biotechnology. 53 (3. 26%. Price Chart. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). The fund's investments total to approximately $6. VHT has a. ETFs Holding XBI. The following charts reflect the geographic spread of WCLD's underlying holdings. 26% rating in the component of Value. 5x and PE ratio is about 14x. 71% of total assets under management. 78% so far this year and in the past one year (as of 11/20/2023), respectively. The XBI holdings are quite variable probably helped by algos. Its price to cash flow multiples is about 13. As of 9/30/23. 65%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. All 33 ARKK ETF Holdings. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. The following charts reflect the allocation of WCLD's underlying. 41% so far this year and in the past one year (as of 01/23/2023), respectively. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. ETF Summary. Top 10 Holdings. Reply Like (7) q. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. S. 22%: Revolution. Top 10 Holdings (14. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. S. 47 million over the past three months. Health Care Fund Highlights: 137 Total Holdings $5. IBB outperformed the S&P 500 last year and did much better than XBI. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. 73m. Neena Mishra May 10, 2023. 84. Below is the comparison between ARKG and XBI. 1 Y 3 Y $ % Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Compare to Open 70. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 01 to $0. No company usually makes up more than two percent of. ETFs - IBB, PBE, XBI. Asset type; Sector; Region; Asset type. MTD. The fund’s NAV was $81. 78% in the last one year. argenx SE ADR. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). We daily evaluate future near-term price gain prospects for quality, market-seasoned ETFs, based on the expectations of market. Holdings Details. View Holdings As of 08/31/2023. 33% from the latest price. Company specialized in: Holding Companies. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. 08 per unit, that means that analysts see 59. 61%) At close: 04:00PM EST Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology. Performance and Risk. 60 as the 52 week high point — that compares with a last trade of $77. Start Free Trial. 26 during this last 52. Free ratings, analyses, holdings, benchmarks, quotes, and news. 00. 7657M. Holdings. Krane Carbon Cfc (138001) 18. View the latest SPDR S&P Biotech ETF (XBI) stock price and news, and other vital information for better exchange traded fund investing. The ETF has lost about -12. . Growth of Hypothetical $10,000. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. Both VHT and XBI are ETFs. This fee is shown as an annual percentage rate (APR). Cash and Equivalents. Performance and Risk The ETF has lost about -9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 3. In seeking to track the performance of the S&P Biotechnology Select. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Holdings. All 142 XBI Holdings. $6. Overview. 18. Taking a look at the XBI, it peaked at $174. 73. The sale of ETFs is subject to an activity assessment fee (from $0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Across the 192 current stocks in the fund, all holdings have a weighting between 0. SPDR S&P Biotech ETF ETF holdings by MarketWatch. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. 80 per share, with $92. By Holdings Channel Staff, updated Friday, November 3, 9:50 AM In total we count 672 hedge funds holding XBI as of their latest 13F filing, but among those we've sorted out just the top ten hedge funds holding XBI by largest position size, and presented them here in slideshow format. 58% and is down about -14. ETF. 46M), Matrix Capital Management Company LP ($188. The fund has a beta of 0. comSPDR S&P Biotech ETF is a equity fund issued by SSgA. ARGX. View complete XLP exchange traded fund holdings for better informed ETF trading. 7% of assets. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. View complete XBI exchange traded fund holdings for better informed ETF trading. The 10 largest holdings have a combined 17. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. SPDR® S&P Biotech ETF XBI. 60 as the 52 week high point — that compares with a last trade of $77. 01%). A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Sector Exposure and Top Holdings. XBI has an overall POWR Rating of D, equating to a Sell. 18% and is down about -39. 08 per unit, that means that analysts see 59. Check out the side-by-side comparison table of IBB vs. Both BBH and XBI are ETFs. ETF Strategies. 17% for the trailing three-year period, which makes XBI a high. XBI holdings. 45% and is down about -9. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. 67% Top 10 holdings are 16. Holdings. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . Comparing the most. The. com if you have any further questions. Looking at the chart above, XBI's low point in its 52 week range is $72. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Total net assets. Follow. 2401 Millstream Rd 125 Victoria BC. Top 10 Holdings. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. Real Estate ETFs. 06 as the 52 week high point — that compares with a last trade of $102. Both IBB and XBI have a similar number of assets under management. 01%). Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Veeva Systems. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. 84 Billion in assets under management, while XBI has 4. Finally, our fifth stock in our POWR Ratings/XBI combination strategy is Regeneron (REGN). Holdings. XBI. VHT has a higher 5-year return than XBI (7. 0. View complete XBI exchange traded fund holdings for better informed ETF trading. 81 and $97. IBB has a higher expense ratio than XBI (0. $7. $5. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Both ARKG and XBI are ETFs. Advertisement. 5% on the day.